Official notice that these drugs can replace 4+7

Xi'an Medical Insurance Bureau issued an emergency notice that a batch of drugs can replace 4 + 7 varieties. On April 1, Xi'an Medical Insurance Bureau issued the Emergency Notice on Implementing the Monitoring Task of the State 4+7 Pilot Work by the Office of the Leading Group for Implementing the Centralized Procurement and Use of Drugs of the State Organization in Xi'an (hereinafter referred to as the Notice). According to the Notice, drug manufacturers, drug circulation enterprises, drug procurement (use), drug use, drug cost structure and drug quality should report to the relevant departments.

Production enterprises need to submit data including inventory turnover days, stop and resume production, price of core raw materials, price of core accessories, etc. From the above data requirements, we can see that the state pays close attention to the supply and price changes of selected drugs. 

(2) Each circulation enterprise responsible for the distribution of 25 selected drugs submits data directly to the Municipal Medical Insurance Bureau. Circulation enterprises need to focus on reporting the situation of return and channel inventory.